Status:
UNKNOWN
Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS
Lead Sponsor:
Uptown Eye Specialists
Conditions:
Cystoid Macular Edema
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess the effects of diabetes mellitus (DM) on anterior chamber cytokine production and postoperative macular edema in patients undergoing femtosecond laser-assisted c...
Detailed Description
As discussed above.
Eligibility Criteria
Inclusion
- All patients who are scheduled for manual cataract surgery or FLACS who have provided informed consent, in accordance with application regulations and guidelines.
- Only one eye from each participant will be included in the study (the first one to be operated on).
Exclusion
- Intravitreal anti-VEGF injection \< 3 months prior to cataract surgery
- Laser photocoagulation \< 3 months prior to cataract surgery
- Complications during manual cataract surgery or FLACS
- Current or previous ocular or systemic inflammation
- History of rheumatic or immune disease
- Poor pharmacologic mydriasis
- Corneal opacities
- Pseudoexfoliation syndrome
- Previous ocular surgery or trauma
- Use of topical or systemic steroids \< 6 months prior to surgery
- Prostaglandin analog eyedrop therapy
- Glaucoma
- Age-related macular degeneration
Key Trial Info
Start Date :
May 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2021
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04856670
Start Date
May 25 2021
End Date
September 15 2021
Last Update
May 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uptown Eye Speicialists
Brampton, Otario, Canada, L6Y0P6